Specifically:
”Of the 14 enrolled, 11 were evaluable for tumor progression assessment per the RECIST1.1 guidelines. The best overall response during the study participation period to date is one complete response, five partial responses, four saw a stabilization of their disease and one saw their disease progress.”
Source: see page 5 of thread below
https://static1.squarespace.com/static/5b63d41b3e2d09b1f56bf483/t/5cf534c68c072e000127d604/1559573706876/IMU_FA_Newsletter_Jun19_web.pdf
Ann: New mimotope cancer vaccine results published, page-23
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
-0.004(6.67%) |
Mkt cap ! $411.5M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 5.9¢ | 5.5¢ | $1.481M | 26.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 400000 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 685507 | 4 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |